Dogwood Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dogwood Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q3 2024.
  • Dogwood Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -217 %, a 98% decline year-over-year.
  • Dogwood Therapeutics, Inc. annual Return On Equity for 2023 was -110 %, a 22.7% increase from 2022.
  • Dogwood Therapeutics, Inc. annual Return On Equity for 2022 was -143 %, a 86.1% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -217 -107 -98% Jul 1, 2024 Sep 30, 2024
Q2 2024 -130 -19 -17% Apr 1, 2024 Jun 30, 2024
Q1 2024 -127 +4.76 +3.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -110 +32.4 +22.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 -110 +32 +22.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -111 +15.6 +12.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -132 -31.4 -31.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -143 -66 -86.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -142 -69 -94.9% Jul 1, 2022 Sep 30, 2022
Q2 2022 -127 Apr 1, 2022 Jun 30, 2022
Q1 2022 -101 Jan 1, 2022 Mar 31, 2022
Q4 2021 -76.6 Oct 1, 2021 Dec 31, 2021
Q3 2021 -72.7 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.